Unconfigured Ad
Collapse
Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by laura, 05-09-2011, 04:42 AM
|
35 responses
107,659 views
0 reactions
|
Last Post
by laura
12-05-2013, 02:37 AM
|
||
|
Started by sci_guy, 01-23-2008, 11:19 PM
|
236 responses
684,338 views
1 reaction
|
Last Post
by ECO
12-25-2009, 06:45 PM
|
||
|
Started by Melissa, 02-12-2014, 09:45 AM
|
0 responses
1,452 views
0 reactions
|
Last Post
by Melissa
02-12-2014, 09:45 AM
|
||
|
Started by lucro, 02-12-2014, 07:46 AM
|
4 responses
2,045 views
0 reactions
|
Last Post
by lucro
02-12-2014, 09:20 AM
|
||
|
Started by rozitaa, 02-12-2014, 08:48 AM
|
0 responses
1,582 views
0 reactions
|
Last Post
by rozitaa
02-12-2014, 08:48 AM
|
||
|
Started by bnfoguy, 06-25-2012, 06:58 AM
|
8 responses
12,033 views
0 reactions
|
Last Post
by cankut
02-12-2014, 05:33 AM
|
||
|
Started by Antony03, 02-09-2014, 05:09 PM
|
2 responses
2,151 views
0 reactions
|
Last Post
by Antony03
02-12-2014, 04:32 AM
|
||
|
Started by susanklein, 02-10-2014, 05:13 AM
|
9 responses
3,687 views
0 reactions
|
Last Post
by maubp
02-12-2014, 03:01 AM
|
||
|
Started by AdrianP, 11-24-2013, 11:48 AM
|
7 responses
4,260 views
0 reactions
|
Last Post
by eriklysoe
02-12-2014, 01:15 AM
|
||
|
Started by Liy, 02-10-2014, 12:21 PM
|
3 responses
2,108 views
0 reactions
|
Last Post
|
||
|
Started by rohan_1925, 02-10-2014, 12:52 PM
|
2 responses
2,591 views
0 reactions
|
Last Post
by m_two
02-11-2014, 01:35 PM
|
||
|
Started by variadevang, 02-10-2014, 09:19 PM
|
3 responses
3,677 views
0 reactions
|
Last Post
by m_two
02-11-2014, 12:56 PM
|
No topics found.
-
Page of 0
-
Filter
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.
Recent Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-24-2026, 12:17 PM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
07-24-2026, 12:17 PM
|
||
|
Started by SEQadmin2, 07-23-2026, 11:41 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
07-23-2026, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
211 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|